FDA is now “open to bayesian statistics”: transformational change or new Pandora’s box?

BMJ 2026

View at publisher

Authors: Peter Doshi

DOI: 10.1136/bmj.s180

Cited by: 2

References: 3

Fields of Study & Subjects

Statistical Methods in Clinical Trials Advanced Causal Inference Techniques Health Systems Economic Evaluations Quality of Life

References 3